Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1997-5-29
pubmed:abstractText
Steroidogenesis begins with the metabolism of cholesterol to pregnenolone by the inner mitochondrial membrane cytochrome P450 side-chain cleavage (P450scc) enzyme. The rate of steroid formation, however, depends on the rate of cholesterol transport from intracellular stores to the inner mitochondrial membrane and loading of P450scc with cholesterol. In previous in vitro studies, we demonstrated that a key element in the regulation of cholesterol transport is the mitochondrial peripheral-type benzodiazepine receptor (PBR). We also showed that the polypeptide diazepam binding inhibitor (DBI), an endogenous PBR ligand, stimulates cholesterol transport and promotes loading of cholesterol to P450scc in vitro, and that its presence is vital for hCG-induced steroidogenesis by Leydig cells. Based on these data and the observations that i) the mitochondrial PBR binding and topography are regulated by hormones; ii) the 18-kDa PBR protein is functionally coupled to the mitochondrial contact site voltage-dependent anion channel protein; iii) the 18-kDa PBR protein is a channel for cholesterol, as shown by molecular modeling and in vitro reconstitution studies; iv) targeted disruption of the PBR gene in steroidogenic cells dramatically reduces the ability of the cells to transport cholesterol in the mitochondria and produce steroids; v) endocrine disruptors, with known anisteroidogenic effect, inhibit PBR ligand binding; and vi) in vivo reduction of adrenal PBR expression results in reduced circulating glucocorticoid levels, we conclude that PBR is an indispensable element of the steroidogenic machinery.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0039-128X
pubmed:author
pubmed:issnType
Print
pubmed:volume
62
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
21-8
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9029710-Animals, pubmed-meshheading:9029710-Binding Sites, pubmed-meshheading:9029710-Biological Transport, pubmed-meshheading:9029710-Carrier Proteins, pubmed-meshheading:9029710-Cell Membrane, pubmed-meshheading:9029710-Cholesterol, pubmed-meshheading:9029710-Chorionic Gonadotropin, pubmed-meshheading:9029710-Cyclic AMP, pubmed-meshheading:9029710-Diazepam Binding Inhibitor, pubmed-meshheading:9029710-Flunitrazepam, pubmed-meshheading:9029710-Humans, pubmed-meshheading:9029710-Mice, pubmed-meshheading:9029710-Mitochondria, pubmed-meshheading:9029710-Models, Biological, pubmed-meshheading:9029710-Models, Molecular, pubmed-meshheading:9029710-Mutation, pubmed-meshheading:9029710-Protein Conformation, pubmed-meshheading:9029710-Receptors, GABA-A, pubmed-meshheading:9029710-Steroids
pubmed:year
1997
pubmed:articleTitle
Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis.
pubmed:affiliation
Department of Cell Biology, Georgetown University Medical Center, Washington, DC 20007, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Review, Research Support, Non-U.S. Gov't